Justin Slaten's Season Is Over, and Boston's October Questions Are Just Beginning

The Boston Red Sox are going to the playoffs. That much has been true for weeks, and the arithmetic is nearly complete — the magic number sits at five, and Boston is effectively locked into the fifth seed in the American League. What remains unsettled is far more interesting: what version of this team actually shows up in October.

The news of the past week did nothing to calm that question.

Start with the bullpen. Justin Slaten is expected to miss the remainder of the season after receiving a platelet-rich plasma injection for what interim manager Chad Tracy described as "degenerative changes in his flexor mass." Slaten had been one of the more reliable arms in a relief corps that already carries a 4.07 ERA and has blown seven saves. He joins Tyron Guerrero on the 15-day list, with Zack Kelly, Kutter Crawford, Johan Oviedo and Eduardo Rivera all parked on the 60-day.

That thinning is not an accident of bad luck alone. Boston spent much of the season trading away pitching depth, and the bill is arriving in September. This is the recurring theme of the Red Sox's second half: a roster that caught fire while short-handed is now being asked to stay upright while even shorter-handed.

The rotation tells the same story. Garrett Crochet, Tanner Houck and Crawford — three pitchers who were supposed to matter in October — are all on the 60-day injured list. Against that backdrop, Sonny Gray's 17-5 record and 2.76 ERA stop being a nice stat line and start being load-bearing infrastructure.

Then there is the offense, which is the actual soft spot. In the last ten games Boston is hitting .210 with a .640 OPS and a .330 slugging percentage. The two losses in Arlington — 4-2 and 7-3 — were the latest evidence of a lineup that struggles specifically against good pitching. Triston Casas, Curtis Mead, Ceddanne Rafaela, Eli White, Anthony Seigler and Masataka Yoshida are all unavailable, which means the club is asking role players to carry regular at-bats into the most demanding month of the year.

The irony is that by most measures this is a strong team. Boston is 82-70 with a plus-82 run differential, and its 44-33 road record is better than its home mark. A club that started 10-17, fired Alex Cora and handed the job to Chad Tracy on an interim basis has authored one of the more remarkable turnarounds in the sport — a historic 31-5 stretch that dragged the season back from the dead.

But the September version looks tired. The Red Sox have gone 5-5 over their last ten games and have been losing to teams they should handle.

None of this changes the standings. The clinch is coming, the champagne is chilling, and the fifth seed is essentially sewn up. The question worth asking is whether a team limping across the finish line — missing its rotation depth, down a leverage reliever, and scoring fewer than four runs a night — is actually building toward October or just surviving until it arrives.

Yoshida could return. Some of the pitching could return. Tracy has publicly said he'd consider carrying an outfielder like Braiden Ward specifically for the postseason roster, which tells you the club is already thinking about the shape of October rather than the remainder of September.

That is the right instinct, because for the 2026 Red Sox, the regular season stopped being the interesting part weeks ago. Whether that's a good thing depends entirely on which team gets off the plane.